Blow to Glenmark: HC restrains it from making anti-diabetes drugs
In a blow to Indian drug firm Glenmark Pharmaceuticals, Delhi High Court Wednesday restrained it from making, selling, advertising, distributing or exporting its anti-diabetes drugs Zita and Zita-Met on the ground that it violated the patent of US pharma major Merck Sharp and Dohme (MSD).
Oct 07, 2015, 22:26 PM IST